Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

被引:127
作者
Smadja, NV
Fruchart, C
Isnard, F
Louvet, C
Dutel, JL
Cheron, N
Grange, MJ
Monconduit, M
Bastard, C
机构
[1] Hop St Antoine, Serv Med Interne Oncol, Lab Cytogenet Hematocancerol, F-75571 Paris 12, France
[2] Ctr Henri Becquerel, F-76038 Rouen, France
[3] Hop Compiegne, Unite Hematol Oncol, Compiegne, France
[4] Hop Bichat, F-75877 Paris, France
关键词
multiple myeloma; chromosomal patterns; cytogenetic abnormalities;
D O I
10.1038/sj.leu.2401041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the cytogenetic results obtained in 81 multiple myeloma (MM) patients with abnormal karyotypes. Most karyotypes were complex with numerical and structural abnormalities but the analysis of chromosomal abnormalities allowed identification of two cytogenetic patterns depending on the chromosome number: a first hyperdiploid pattern (54%) with recurrent trisomies 3, 5, 7, 9, 11, 15 and 19 and a second pattern (46%) showing either pseudodiploid, hypodiploid or near-tetraploid karyotypes. Structural abnormalities were present in ail but five hyperdiploid karyotypes, and frequently involved lymphoid breakpoints: immunoglobulin gene regions (36 cases) or chromosome 11q13 region (21 cases). Numerous other structural aberrations were detected; the most frequent involved chromosome 1 and chromosome 13. Structural abnormalities were significantly more frequent in the second hypodiploid group. When analyzing the results obtained in the 60 patients studied at the time of diagnosis, a prognostic correlation was found between the cytogenetic pattern and overall survival: hyperdiploid patients had a longer survival than patients belonging to the pseudo/hypo/near-tetraploid group (median survival 36.8 vs 18.2 months, P < 0.04). These results suggest that MM could correspond to two closely related diseases.
引用
收藏
页码:960 / 969
页数:10
相关论文
共 38 条
[31]   CYTOGENETIC STUDY IN MULTIPLE-MYELOMA AT DIAGNOSIS - COMPARISON OF 2 TECHNIQUES [J].
SMADJA, NV ;
LOUVET, C ;
ISNARD, F ;
DUTEL, JL ;
GRANGE, M ;
VARETTE, C ;
KRULIK, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) :619-624
[32]   BICLONAL AND HYPODIPLOID MULTIPLE-MYELOMA [J].
SMITH, L ;
BARLOGIE, B ;
ALEXANIAN, R .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (05) :841-843
[33]   NONRANDOM CHROMOSOMAL REARRANGEMENTS OF 14Q32.3 AND 19P13.3 AND PREFERENTIAL DELETION OF 1P IN 21 PATIENTS WITH MULTIPLE-MYELOMA AND PLASMA-CELL LEUKEMIA [J].
TANIWAKI, M ;
NISHIDA, K ;
TAKASHIMA, T ;
NAKAGAWA, H ;
FUJII, H ;
TAMAKI, T ;
SHIMAZAKI, C ;
HORIIKE, S ;
MISAWA, S ;
ABE, T ;
KASHIMA, K .
BLOOD, 1994, 84 (07) :2283-2290
[34]   POOR-PROGNOSIS IN MULTIPLE-MYELOMA IS ASSOCIATED ONLY WITH PARTIAL OR COMPLETE DELETIONS OF CHROMOSOME-13 OR ABNORMALITIES INVOLVING 11Q AND NOT WITH OTHER KARYOTYPE ABNORMALITIES [J].
TRICOT, G ;
BARLOGIE, B ;
JAGANNATH, S ;
BRACY, D ;
MATTER, S ;
VESOLE, DH ;
NAUCKE, S ;
SAWYER, JR .
BLOOD, 1995, 86 (11) :4250-4256
[35]   Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants [J].
Tricot, G ;
Sawyer, JR ;
Jagannath, S ;
Desikan, KR ;
Siegel, D ;
Naucke, S ;
Mattox, S ;
Bracy, D ;
Munshi, N ;
Barlogie, B .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2659-2666
[36]   KARYOTYPE IN MULTIPLE-MYELOMA AND PLASMA-CELL LEUKEMIA [J].
WEH, HJ ;
GUTENSOHN, K ;
SELBACH, J ;
KRUSE, R ;
WACKERBACKHAUS, G ;
SEEGER, D ;
FIEDLER, W ;
FETT, W ;
HOSSFELD, DK .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) :1269-1273
[37]  
Zandecki M, 1996, BRIT J HAEMATOL, V94, P217
[38]   IMAGE-ANALYSIS IN MULTIPLE-MYELOMA AT DIAGNOSIS - CORRELATION WITH CYTOGENETIC STUDY [J].
ZANDECKI, M ;
BERNARDI, F ;
LAI, JL ;
FACON, T ;
IZYDORCZYK, V ;
BAUTERS, F ;
COSSON, A .
CANCER GENETICS AND CYTOGENETICS, 1994, 74 (02) :115-119